Back to Search
Start Over
Use of the Dyskinesia Impairment Scale in non-ambulatory dyskinetic cerebral palsy.
- Source :
-
Developmental medicine and child neurology [Dev Med Child Neurol] 2020 Apr; Vol. 62 (4), pp. 494-499. Date of Electronic Publication: 2019 Nov 29. - Publication Year :
- 2020
-
Abstract
- Aim: To assess the responsiveness, concurrent validity, and feasibility of the Dyskinesia Impairment Scale (DIS) in non-ambulatory patients with dyskinetic cerebral palsy (CP).<br />Method: The study is a secondary analysis of data collected in the IDYS trial, a randomized controlled trial on the effects of intrathecal baclofen (ITB). The DIS and Barry-Albright Dystonia Scale (BADS) were conducted at baseline and after 3 months of ITB or placebo treatment. Responsiveness was assessed by comparing the effect sizes and correlation of change after treatment between the DIS and BADS. Concurrent validity was evaluated by assessing the correlations between scales. Feasibility was evaluated for each DIS item by the number of participants who successfully accomplished the item.<br />Results: Thirty-three non-ambulatory patients (9 females, 24 males) with dyskinetic CP (ITB-treated: n=17, mean [SD] age: 14y 1mo [4y 1mo]; placebo-treated: n=16, mean [SD] age: 14y 7mo [4y]) were included in the study. The effect sizes for BADS and DIS were similar in The ITB-treated group (-0.29 and -0.22 respectively). Changes after treatment on the DIS dystonia subscale correlated with changes on the BADS (r=0.64; p<0.001). The DIS dystonia subscale and BADS correlated at baseline and follow-up (r=0.78; p<0.001 and r=0.79; p<0.001). Not all DIS activity items could be performed in this sample of patients.<br />Interpretation: For non-ambulatory patients with dyskinetic CP, the responsiveness of the DIS equalled the responsiveness of BADS. Concurrent validity was adequate. Feasibility for activity items was restricted in patients with severe dyskinetic CP.<br />What This Paper Adds: The Dyskinesia Impairment Scale (DIS) and Barry-Albright Dystonia Scale showed similar responsiveness in non-ambulatory patients with dyskinetic cerebral palsy (CP). No floor or ceiling effect was observed for DIS in non-ambulatory participants. The concurrent validity of DIS was adequate in non-ambulatory participants. Patients with dyskinetic CP in Gross Motor Function Classification System levels IV and V could not perform all DIS activity items.<br /> (© 2019 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.)
- Subjects :
- Adolescent
Baclofen administration & dosage
Baclofen therapeutic use
Cerebral Palsy drug therapy
Cerebral Palsy physiopathology
Child
Disability Evaluation
Dyskinesias drug therapy
Dyskinesias physiopathology
Female
Humans
Injections, Spinal
Male
Muscle Relaxants, Central administration & dosage
Muscle Relaxants, Central therapeutic use
Severity of Illness Index
Treatment Outcome
Young Adult
Cerebral Palsy diagnosis
Dyskinesias diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1469-8749
- Volume :
- 62
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Developmental medicine and child neurology
- Publication Type :
- Academic Journal
- Accession number :
- 31784988
- Full Text :
- https://doi.org/10.1111/dmcn.14415